IL6 and cancer: Likewise, in the MDCa@RBC‐Alipo treatment group, significantly elevated levels of serum cytokines such as TNF‐α, IL‐6, and IL1‐β, which play crucial roles in cellular immunity against cancer, were observed (Figure 5L).